Cargando…

WT1 Pulsed Human CD141+ Dendritic Cell Vaccine Has High Potential in Solid Tumor-Targeted Immunotherapy

Dendritic cells (DC) are powerful cells that play critical roles in anti-tumor immunity, and their use in cancer immunotherapy unlocks hidden capabilities as an effective therapeutic. In order to maximize the full potential of DC, we developed a DC vaccine named CellgramDC-WT1 (CDW). CDW was pulsed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Sung Yoon, Jeong, Seong Mun, Jeon, Young Joo, Yang, Sun Ja, Hwang, Ju Eun, Yoo, Byung Moo, Kim, Hyun Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864659/ https://www.ncbi.nlm.nih.gov/pubmed/36675017 http://dx.doi.org/10.3390/ijms24021501

Ejemplares similares

Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141(+) dendritic cells to activate naïve and memory WT1‐specific CD8(+) T cells
por: Pearson, Frances E, et al.
Publicado: (2020)

Circulating precursors of human CD1c(+) and CD141(+) dendritic cells
por: Breton, Gaëlle, et al.
Publicado: (2015)

Differential Gene Expression in Thrombomodulin (TM; CD141)(+) and TM(−) Dendritic Cell Subsets
por: Toda, Masaaki, et al.
Publicado: (2013)

Human Tissues Contain CD141(hi) Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103(+) Nonlymphoid Dendritic Cells
por: Haniffa, Muzlifah, et al.
Publicado: (2012)

Coexpression of CD163 and CD141 identifies human circulating IL-10-producing dendritic cells (DC-10)
por: Comi, Michela, et al.
Publicado: (2019)

Inhibition of LSD1 in MDS Progenitors Restores Differentiation of CD141(Hi) Conventional Dendritic Cells
por: Srivastava, Pragya, et al.
Publicado: (2020)

Human skin CD141(+) dendritic cells regulate cutaneous immunity via the neuropeptide urocortin 2
por: Lui, Prudence PokWai, et al.
Publicado: (2023)

Dendritic Cell-Based Immunotherapy for Solid Tumors()()
por: Jung, Nam-Chul, et al.
Publicado: (2018)

Human CD141(+) Dendritic Cell and CD1c(+) Dendritic Cell Undergo Concordant Early Genetic Programming after Activation in Humanized Mice In Vivo
por: Minoda, Yoshihito, et al.
Publicado: (2017)

Langerin-expressing dendritic cells in human tissues are related to CD1c(+) dendritic cells and distinct from Langerhans cells and CD141(high) XCR1(+) dendritic cells
por: Bigley, Venetia, et al.
Publicado: (2015)

Human dendritic cells (DCs) are derived from distinct circulating precursors that are precommitted to become CD1c(+) or CD141(+) DCs
por: Breton, Gaëlle, et al.
Publicado: (2016)

Metabolomic and lipidomic signatures associated with activation of human cDC1 (BDCA3(+)/CD141(+)) dendritic cells
por: Basit, Farhan, et al.
Publicado: (2021)

Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies
por: Letsch, Anne, et al.
Publicado: (2013)

Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
por: Dolcetti, Riccardo, et al.
Publicado: (2020)

Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141(+) Subset
por: Sachamitr, Patty, et al.
Publicado: (2018)

Superior antigen cross-presentation and XCR1 expression define human CD11c(+)CD141(+) cells as homologues of mouse CD8(+) dendritic cells
por: Bachem, Annabell, et al.
Publicado: (2010)

Retinoic acid treated human dendritic cells induce T regulatory cells via the expression of CD141 and GARP which is impaired with age
por: Agrawal, Sudhanshu, et al.
Publicado: (2016)

WT1 peptide-based immunotherapy for refractory thymic epithelial malignancies
por: Suzuki, Mikito, et al.
Publicado: (2019)

Resident CD141 (BDCA3)(+) dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation
por: Chu, Chung-Ching, et al.
Publicado: (2012)

Priming of PRAME- and WT1-specific CD8(+) T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapy
por: van den Ancker, Willemijn, et al.
Publicado: (2013)

Immunotherapy of Malignant Melanoma with Tumor Lysate-Pulsed Autologous Monocyte-Derived Dendritic Cells
por: Kim, Dae Suk, et al.
Publicado: (2011)

Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors
por: Kalkusova, Katerina, et al.
Publicado: (2022)

An overlooked subset of Cx3cr1(wt/wt) microglia in the Cx3cr1(CreER-Eyfp/wt) mouse has a repopulation advantage over Cx3cr1(CreER-Eyfp/wt) microglia following microglial depletion
por: Zhou, Kai, et al.
Publicado: (2022)

Human CD141(+) (BDCA-3)(+) dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
por: Jongbloed, Sarah L., et al.
Publicado: (2010)

The Superior Ability of Human BDCA3(+) (CD141(+)) Dendritic Cells (DCs) to Cross-Present Antigens Derived From Necrotic Lung Cancer Cells
por: Gu, Fei-fei, et al.
Publicado: (2020)

WT1 Peptide Cancer Vaccine for Patients with Hematopoietic Malignancies and Solid Cancers
por: Oka, Yoshihiro, et al.
Publicado: (2007)

The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy
por: Wo, Yu Jun, et al.
Publicado: (2019)

Targeting CD24 as a novel immunotherapy for solid cancers
por: Yang, Yan, et al.
Publicado: (2023)

Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141(+) dendritic cells to activate naïve and memory NY-ESO-1-specific CD8(+) T cells
por: Masterman, Kelly-Anne, et al.
Publicado: (2020)

PD-L1-directed PlGF/VEGF blockade synergizes with chemotherapy by targeting CD141(+) cancer-associated fibroblasts in pancreatic cancer
por: Kim, Duk Ki, et al.
Publicado: (2022)

Effect of pulse-current-based protocols on the lithium dendrite formation and evolution in all-solid-state batteries
por: Reisecker, V., et al.
Publicado: (2023)

141st LHCC Meeting
Publicado: (2020)

141st SPSC Meeting
Publicado: (2021)

Diagnosing the miR-141 prostate cancer biomarker using nucleic acid-functionalized CdSe/ZnS QDs and telomerase
por: Jou, Amily Fang-ju, et al.
Publicado: (2015)

Prognostic Role of MicroRNA-200c-141 Cluster in Various Human Solid Malignant Neoplasms
por: Li, Xiao-yang, et al.
Publicado: (2015)

Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
por: TADA, FUJIMASA, et al.
Publicado: (2012)

Human CD141(+) dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model
por: Lee, Yoke Seng, et al.
Publicado: (2021)

Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141(+) Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8(+) T Cell Response in Human Immune System Mice
por: Huang, Jing, et al.
Publicado: (2020)

Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma
por: Vogt, Annabelle, et al.
Publicado: (2021)

Cytotoxicity of WT1-reactive T cells against Wilms tumor: An implication for antigen-specific adoptive immunotherapy
por: Monzavi, Seyed Mostafa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v6rbm3t6fvjqtll6o851gceeja